GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » Interest Expense

Genetic Signatures (ASX:GSS) Interest Expense : A$-0.08 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Genetic Signatures Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Genetic Signatures's interest expense for the six months ended in Dec. 2024 was A$ -0.05 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.08 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Genetic Signatures's Operating Income for the six months ended in Dec. 2024 was A$ -9.23 Mil. Genetic Signatures's Interest Expense for the six months ended in Dec. 2024 was A$ -0.05 Mil. Genetic Signatures did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Genetic Signatures Interest Expense Historical Data

The historical data trend for Genetic Signatures's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Signatures Interest Expense Chart

Genetic Signatures Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 -0.04 -0.02 - -0.04

Genetic Signatures Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -0.04 -0.05

Genetic Signatures Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genetic Signatures  (ASX:GSS) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Genetic Signatures's Interest Expense for the six months ended in Dec. 2024 was A$-0.05 Mil. Its Operating Income for the six months ended in Dec. 2024 was A$-9.23 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was A$0.60 Mil.

Genetic Signatures's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Genetic Signatures did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Genetic Signatures Business Description

Traded in Other Exchanges
N/A
Address
7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042
Genetic Signatures Ltd is a specialist molecular diagnostics company, specialising in syndromic multiplex real-time PCR testing. The company offers products for the routine detection of infectious diseases and pathogens. It has three operating segments based on regions: Asia Pacific, EMEA, and Americas. It generates the majority of its revenue from the Asia Pacific region. The group's operations are primarily based in Australia, with sales and support teams in the UK, Germany, and the United States.